LONDON, June 26 (Reuters) - Epoetin, or Epo, drugs should carry a new warning for their use in cancer patients stating that blood transfusion should be the preferred method of correcting anaemia, the European Medicines Agency said on Thursday.
LONDON, June 26 (Reuters) - Epoetin, or Epo, drugs should carry a new warning for their use in cancer patients stating that blood transfusion should be the preferred method of correcting anaemia, the European Medicines Agency said on Thursday.